| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.081 | 0.06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |